08.08.2017
- As its financial woes continue to deepen, Israeli generics producer Teva is making plans to lay off 7,000 employees and close 15 plants. CEO Yitzhak Peterburg said the company will...
08.05.2017
- Major drug makers Allergan and Novartis are collaborating to test a new combination therapy for non-alcoholic steatohepatitis (NASH), a progressive form of fatty liver disease said...
20.03.2017
- Allergan has secured exclusive access to Editas Medicine’s genome-editing ocular programs under a strategic research and development agreement. The deal covers early stage, first...
15.03.2017
- US activist investor Bill Ackman is pulling the plug on his Pershing Square Capital Management hedge fund’s loss-making engagement in drugmaker Valeant. After the close of trading...
22.02.2017
- Allergan’s spending spree shows no sign of stopping. It its latest move, the Ireland- based former US drugmaker has agreed to pay nearly $2.5 billion for Zeltiq Aesthetics, a US...
10.02.2017
- Israeli drugmaker – the world’s largest generics producer – has moved into the spotlight again, days after it said it was replacing its CEO Erez Vigodman. According to the Israeli...
13.01.2017
- American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...
24.11.2016
- Irish drugmaker Allergan has beefed up its pipeline for neurodegenerative disorders with the acquisition of US-based Chase Pharmaceuticals. Under the terms of the deal, Allergan...
